Protein-polymer conjugates are used to treat several diseases. PEGylation, i.e. the modification with poly(ethylene glycol) (PEG) is the currently used strategy. However, due to its non-biodegradability, the design of effective and degradable conjugates is of both academic and industry potential. We present the preparation and studies of the activity and stability of novel biodegradable myoglobin-polyphosphoester conjugates. Poly(ethyl ethylene phosphate) (PEEP) is a water-soluble polyphosphoester, which had been reported to be biocompatible and biodegradable. PEEP is a promising candidate as a degradable substitute for the "gold standard" PEG, which can cause long-term effects, as it is not degradable. PEEPylated conjugates with a variable degree of polymer grafting were synthesized, characterized (with online triple detection size exclusion chromatography, mass spectrometry, and gel electrophoresis), and compared with PEGylated analogs. We highlight differences in how the structure, the number, and the length of the polymer influence the properties of the conjugates. Overall, the analyses conducted (including activity assay, calorimetry, and fluorimetry measurements) show that the covalent attachment of the polymer does not irrevocably affect the protein's features under physiological conditions, suggesting the potential of this new class of polymers for the design of a new generation of fully degradable conjugates.
Polyphosphoesters
(PPEs), a versatile class of biodegradable and
biocompatible polymers, have been proposed as alternatives to poly(ethylene
glycol) (PEG), which is suspected to be responsible for anaphylactic
reactions in some patients after the administration of PEGylated compounds,
e.g., in the current Covid-19 vaccines. We present the synthesis and
characterization of a novel set of protein–polymer conjugates
using the model protein myoglobin and a set of PPEs with different
hydrophilicity and molar mass. We report an extensive evaluation of
the (bio)physical properties of the protein within the conjugates,
studying its conformation, residual activity, and thermal stability
by complementary techniques (UV–vis spectroscopy, nano-differential
scanning calorimetry, and fluorometry). The data underline the systematic
influence of polymer hydrophilicity on protein properties. The more
hydrophobic polymers destabilize the protein, the more hydrophilic
PPEs protect against thermally induced aggregation and proteolytic
degradation. This basic study aims at guiding the design of future
PPEylated drugs and protein conjugates.
PEGylated proteins are widely used for therapeutic applications, therefore a fundamental understanding of the conjugates' structure and their behaviour in solution is essential to promote new developments in this field. In the present work, myoglobin-poly(ethylene glycol) conjugates were synthesized and studied by using differential scanning calorimetry and UV-visible spectroscopy to obtain information on the bioconjugates' thermodynamic stability, also focusing on the PEG's role on the solvent-protein surface interaction. The overall results of this study indicated a thermal destabilization of the proteins that follows the extent of the bioconjugation without, however, compromising the native structure which remains functional. Moreover, the myoglobin PEGylation prevented the post-denaturation aggregation phenomena and enhanced the protein thermal reversibility. The thermodynamic interpretation of the data indicated that the bioconjugation influences the solvent-exposed protein surface difference between native and denatured state, contributing to the interpretation of the overall protein modification and functionality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.